title: [Effect of danshensu on activation of JNK pathway in hepatic stellate cells(HSCs) induced by IL-1 beta].
abstract: OBJECTIVE
  To investigate the inhibitory effect of danshensu on the activation of JNK signaling in rat hepatic stellate cells (HSCs) induced by IL-1beta.
  
  
  METHODS
  The proliferation of primary rat HSCs treated with different concentration of Danshensu was checked by MTT colorimetric assay. The expression and phosphorylation of JNK and P-JNK was detected by western blotting. Synthesis and secretion of collagen I were detected by the quantitative immunocytochemical assay and ELISA.
  
  
  RESULTS
  Danshensu inhibited the proliferation of HSCs in a dose-dependent manner. At the concentration of 0.0625 to 0.25 mmol/L, Danshensu significantly repressed the proliferation of HSC induced by IL-1beta (P < 0.05). Synthesis and secretion of Type I collagen was significantly decreased 24 hours after 0.25 mmol/L Danshensu treatment (P < 0.01). The phosphorylation of JNK induced by IL-1beta was significantly inhibited by Danshensu treatment (P < 0.05), however, the expression of JNK was not regulated by Danshensu.
  
  
  CONCLUSIONS
  Danshensu represses the activation and proliferation of HSCs, and inhibits the synthesis and secretion of Type I collagen, possibly via the repression of the JNK signal transduction.
authors: Department of Gastroenterology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors: Bin-bin
authors: BB
authors: Yu
authors: Li-li
authors: LL
authors: Dai
authors: Xin
authors: X
authors: Li
authors: Dong
authors: D
authors: Li
authors: Zhong-hua
authors: ZH
authors: Jiang
mesh_terms: D000818:Animals; D015153:Blotting, Western; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D024042:Collagen Type I / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation; D055166:Hepatic Stellate Cells / Q000187:drug effects* / Q000378:metabolism; D007150:Immunohistochemistry; D053583:Interleukin-1beta / Q000494:pharmacology; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism*; D007773:Lactates / Q000008:administration & dosage / Q000494:pharmacology*; D008103:Liver Cirrhosis / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D024042:Collagen Type I; D053583:Interleukin-1beta; D007773:Lactates; C035055:3,4-dihydroxyphenyllactic acid; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases